Synjardy XR 1000 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 1000 mg/1

Synjardy XR 1000 mg/1 combines empagliflozin and metformin hydrochloride for type 2 diabetes management. This extended-release tablet supports blood sugar control. Buy Synjardy XR online for convenient diabetes care.

Strength

1000 mg/1

Pack Size

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0280-90)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 1000 mg/1 is used to manage type 2 diabetes in adults. It combines empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and metformin hydrochloride, a biguanide. This combination helps lower blood sugar levels. People often ask, 'What is Synjardy XR used for?' It is typically prescribed as part of a broader diabetes management plan, including diet and exercise.

Side Effects

Common effects of Synjardy XR 1000 mg/1 may include urinary tract infections, nausea, and diarrhea. Some users experience genital mycotic infections due to the empagliflozin component. Extended-release tablets are designed to minimize gastrointestinal side effects associated with metformin.

Precautions & Warnings

Handle Synjardy XR 1000 mg/1 with care, especially if you have kidney issues or are on a low-sodium diet. Avoid alcohol while taking this medication, as it can increase the risk of lactic acidosis. Store the tablets at room temperature, away from moisture and heat.

Avoid Interactions

Synjardy XR 1000 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Always inform your healthcare provider about all medications you are taking. Alcohol can increase the risk of lactic acidosis, so it is best to avoid it while using this medication.

Frequently Asked Questions

Synjardy XR 1000 mg/1 is used to manage type 2 diabetes in adults by helping to lower blood sugar levels.

Synjardy XR 1000 mg/1 is an extended-release tablet taken orally, typically once daily with a meal.

Common side effects include urinary tract infections, nausea, diarrhea, and genital mycotic infections.

It is best to avoid alcohol while taking Synjardy XR 1000 mg/1, as it can increase the risk of lactic acidosis.

Store Synjardy XR 1000 mg/1 at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.